Our results show that visfatin promotes the phosphorylation of ERK, p38, and JNK, while their respective pharmacological inhibitors suppress visfatin-induced promotion of MMP-2 expression and chondrosarcoma cell migration. The gene discussed is MAPK8; the disease is chondrosarcoma.